Saturday - May 17, 2025

LOGIN  |  REGISTER
Assertio
Cue Biopharma

Oscar Health 2025 First Quarter Earnings Conference Call

April 09, 2025 | Last Trade: US$17.52 0.96 5.80

NEW YORK / Apr 09, 2025 / Business Wire / Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025.

Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows:

Live Call: 1.855.761.5600
Conference ID: 7768132
Webcast

The call will be archived and available on Oscar’s investor relations website (ir.hioscar.com) following May 7, 2025 for a period of 90 days.

About Oscar Health

Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.8 million members, as of February 1, 2025.

C4 Therapeutics

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page